Cargando…

Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan

BACKGROUND: Little evidence supports anticoagulant therapy as effective adjuvant therapy to reduce mortality overall in sepsis. However, several studies suggest that anticoagulant therapy may reduce mortality in specific patients. This study aimed to identify a subset of patients with high benefit p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamakawa, Kazuma, Umemura, Yutaka, Hayakawa, Mineji, Kudo, Daisuke, Sanui, Masamitsu, Takahashi, Hiroki, Yoshikawa, Yoshiaki, Hamasaki, Toshimitsu, Fujimi, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966726/ https://www.ncbi.nlm.nih.gov/pubmed/27472991 http://dx.doi.org/10.1186/s13054-016-1415-1

Ejemplares similares

Concomitant Versus Individual Administration of Antithrombin and Thrombomodulin for Sepsis-Induced Disseminated Intravascular Coagulation: A Nationwide Japanese Registry Study
por: Umemura, Yutaka, et al.
Publicado: (2018)

Nationwide registry of sepsis patients in Japan focused on disseminated intravascular coagulation 2011–2013
por: Hayakawa, Mineji, et al.
Publicado: (2018)

Optimal Timing and Early Intervention With Anticoagulant Therapy for Sepsis-Induced Disseminated Intravascular Coagulation
por: Yamakawa, Kazuma, et al.
Publicado: (2019)

The Treatment Intensity of Anticoagulant Therapy for Patients With Sepsis-Induced Disseminated Intravascular Coagulation and Outcomes: A Multicenter Cohort Study
por: Kudo, Daisuke, et al.
Publicado: (2019)

Web-based application for predicting the potential target phenotype for recombinant human thrombomodulin therapy in patients with sepsis: analysis of three multicentre registries
por: Goto, Tadahiro, et al.
Publicado: (2022)

Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
por: Yoshimura, Jumpei, et al.
Publicado: (2015)

Anticoagulant therapies against sepsis‐induced disseminated intravascular coagulation
por: Umemura, Yutaka, et al.
Publicado: (2023)

Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin: an analysis of three multicentre observational studies
por: Kudo, Daisuke, et al.
Publicado: (2021)

Optimal Antithrombin Activity Threshold for Initiating Antithrombin Supplementation in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study
por: Hayakawa, Mineji, et al.
Publicado: (2018)

The Survival Benefit of a Novel Trauma Workflow that Includes Immediate Whole-body Computed Tomography, Surgery, and Interventional Radiology, All in One Trauma Resuscitation Room: A Retrospective Historical Control Study
por: Kinoshita, Takahiro, et al.
Publicado: (2019)

Non-linear and Interaction Analyses of Biomarkers for Organ Dysfunctions as Predictive Markers for Sepsis: A Nationwide Retrospective Study
por: Umemura, Yutaka, et al.
Publicado: (2022)

Efficacy of Carbapenems Compared With Noncarbapenem Broad-Spectrum Beta-Lactam Antibiotics as Initial Antibiotic Therapy Against Sepsis: A Nationwide Observational Study*
por: Umemura, Yutaka, et al.
Publicado: (2023)

Impact on survival of whole-body computed tomography before emergency bleeding control in patients with severe blunt trauma
por: Wada, Daiki, et al.
Publicado: (2013)

Age Is Associated With the Efficacy of Anticoagulant Therapies Against Sepsis-Induced Disseminated Intravascular Coagulation
por: Takahashi, Kyosuke, et al.
Publicado: (2021)

Hematological Phenotype of COVID-19-Induced Coagulopathy: Far from Typical Sepsis-Induced Coagulopathy
por: Umemura, Yutaka, et al.
Publicado: (2020)

Impact of Gram stain results on initial treatment selection in patients with ventilator-associated pneumonia: a retrospective analysis of two treatment algorithms
por: Yoshimura, Jumpei, et al.
Publicado: (2017)

Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study
por: Yamakawa, Kazuma, et al.
Publicado: (2011)

Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
por: Yamakawa, Kazuma, et al.
Publicado: (2013)

Targeted therapy using polymyxin B hemadsorption in patients with sepsis: a post-hoc analysis of the JSEPTIC-DIC study and the EUPHRATES trial
por: Osawa, Itsuki, et al.
Publicado: (2023)

Assessment of risk factors related to healthcare-associated methicillin-resistant Staphylococcus aureus infection at patient admission to an intensive care unit in Japan
por: Yamakawa, Kazuma, et al.
Publicado: (2011)

Emergency administration of fibrinogen concentrate for hemorrhage: A protocol for systematic review and meta-analysis
por: Itagaki, Yuki, et al.
Publicado: (2021)

Effect of Earlier Door-to-CT and Door-to-Bleeding Control in Severe Blunt Trauma: A Retrospective Cohort Study
por: Murao, Shuhei, et al.
Publicado: (2021)

Residual persistence of cytotoxicity lymphocytes and regulatory T cells in patients with severe coronavirus disease 2019 over a 1‐year recovery process
por: Mitsuyama, Yumi, et al.
Publicado: (2022)

Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced DIC
por: Yamakawa, K, et al.
Publicado: (2014)

Emergency administration of fibrinogen concentrate for haemorrhage: systematic review and meta-analysis
por: Itagaki, Yuki, et al.
Publicado: (2023)

A Systematic Summary of Systematic Reviews on Anticoagulant Therapy in Sepsis
por: Murao, Shuhei, et al.
Publicado: (2019)

Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock
por: Iizuka, Yusuke, et al.
Publicado: (2017)

Characteristics, treatments, and outcomes of severe sepsis of 3195 ICU-treated adult patients throughout Japan during 2011–2013
por: Hayakawa, Mineji, et al.
Publicado: (2016)

Efficacy and safety of nintedanib for pulmonary fibrosis in severe pneumonia induced by COVID-19: An interventional study
por: Umemura, Yutaka, et al.
Publicado: (2021)

Impaired balance between coagulation and fibrinolysis plays a prominent role in patients with sepsis
por: Umemura, Y, et al.
Publicado: (2014)

Low dose immunoglobulin g for treatment of severe sepsis and septic shock
por: Iizuka, Y, et al.
Publicado: (2015)

Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis
por: Kondo, Yutaka, et al.
Publicado: (2019)

Different hemoglobin thresholds for transfusion in patients with severe sepsis and septic shock
por: Kamio, T, et al.
Publicado: (2015)

Impact of initial coagulation and fibrinolytic markers on mortality in patients with severe blunt trauma: a multicentre retrospective observational study
por: Ishii, Kenta, et al.
Publicado: (2019)

Intensive care with extracorporeal membrane oxygenation rewarming in accident severe hypothermia (ICE-CRASH) study: a protocol for a multicentre prospective, observational study in Japan
por: Takauji, Shuhei, et al.
Publicado: (2021)

The Vasopressin Loading for Refractory septic shock (VALOR) study: a prospective observational study
por: Nakamura, Kensuke, et al.
Publicado: (2023)

Galápagosization of sepsis management in Japan: a nationwide survey of current practices
por: Yamakawa, Kazuma, et al.
Publicado: (2020)

First clinical experience with IVR-CT system in the emergency room: Positive impact on trauma workflow
por: Wada, Daiki, et al.
Publicado: (2012)

Gram stain-guided antibiotic choice: a GRACEful method to safely restrict overuse of broad-spectrum antibiotic agents
por: Yoshimura, Jumpei, et al.
Publicado: (2018)

Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series
por: Nakamura, Kensuke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o13u471ugf2vj8doh5okepban6